Get 20% lifetime commission for referring investors to digrin.com
here.
Foghorn Therapeutics Inc. (FHTX) Financials
FHTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 203.4 million | 284.4 million |
| March 31, 2026 | 222.2 million | 298.6 million |
| Dec. 31, 2025 | 198.1 million | 306.6 million |
| Sept. 30, 2025 | 205.0 million | 294.6 million |
FHTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -19.0 million | 2.6 million |
| March 31, 2026 | -25.3 million | 2.4 million |
| Dec. 31, 2025 | -22.3 million | 2.2 million |
| Sept. 30, 2025 | -18.9 million | 2.7 million |
FHTX Net Income
No data available :(
FHTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 167.6 million | - | 43.1 million |
| March 31, 2026 | 184.9 million | - | 40.1 million |
| Dec. 31, 2025 | 158.9 million | - | 41.3 million |
| Sept. 30, 2025 | 180.3 million | - | 22.5 million |
FHTX Shares Outstanding
FHTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 50000 | 18.5 million | 6.4 million | - |
| March 31, 2026 | - | 18.3 million | 6.6 million | - |
| Dec. 31, 2025 | - | 22.9 million | 6.8 million | - |
| Sept. 30, 2025 | - | 20.0 million | 6.7 million | - |
FHTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 16.1 million | - |
| March 31, 2026 | 3.3 million | 238000 |
| Dec. 31, 2025 | 9.2 million | 802000 |
| Sept. 30, 2025 | 8.2 million | 20.0 million |
FHTX
Price: $6.74
52 week price:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18512
Market Capitalization: 371.8 million